Schrör K

No ORCID on file · 1 paper in corpus · active 2009
2009
British journal of pharmacology ·doi:10.1111/j.1476-5381.2009.00470.x

Background and purposeThe risk for cardiovascular events including venous and arterial disease and stroke is elevated after treatment with estrogen and medroxyprogesterone acetate (MPA) in postmenopausal women. Here, we have investigated th…